BC Platforms

BC Platforms is a global technology company founded in Finland in 1997 and headquartered in Zurich, Switzerland, that accelerates medical innovation and improves health outcomes through advanced technology, predictive analytics, and comprehensive patient data. The company empowers healthcare and life sciences organizations to transform drug development and precision medicine by enabling faster, better-informed decisions. With more than 25 years of experience, BC Platforms serves top 20 pharmaceutical companies and over 150 healthcare organizations across the US, Europe, Asia-Pacific, and the Middle East, providing access to more than 187 million patients — over 90% of whom are located outside the United States.

BC Platforms operates as a one-stop, flexible, and scalable solution for data provisioning, analytics, and collaboration. Its AI-enabled federated architecture connects users securely across a global network of hospitals, research centers, and biobanks, delivering deep and novel insights at a fraction of the cost and time typically required for real-world data research at this scale. The platform meets EHDS and GDPR+ standards and has supported more than 20 FDA and EMA regulatory submissions.

Core Products and Modules

• BC Unify: An AI-driven, end-to-end data mastering platform that ingests, harmonizes, transforms, and enriches multi-modal data. It automates data processing and workflows, ensuring data is anonymized, integrated, and ready to use across a wide array of advanced use cases and stakeholders.
• BC Catalyst: A prompt-based, AI-native precision medicine platform that makes complex genomic and real-world clinical data actionable across the entire drug lifecycle. It enables users to quickly identify patient cohorts, select biomarkers, and analyze standard of care, and is described as a first-to-market AI-native analytics product.
• BC Image: A single, end-to-end platform for advanced and efficient image processing. It streamlines the extraction, export, and organization of imaging files, enabling analysis of large image datasets while remaining GDPR compliant and without compromising data quality.
• BC Mosaic: A trusted research environment (TRE) for managing research using real-world and clinical trial data. It significantly increases analytical capacity for complex bioinformatics through data discovery and feasibility tools, data visualizations, and a regulatory-compliant audit trail. BC Mosaic is available on AWS Marketplace and features NVIDIA accelerated computing, delivering up to 80x faster analytics across multi-modal health data.

Data Assets and Research-Ready Datasets

• Extensive curated datasets including clinical data, electronic medical records (EMRs), eCRFs, laboratory data, multi-omics, and imaging data.
• Coverage across multiple therapeutic areas including oncology, neurology, rare diseases, and immunology.
• Support for structured and unstructured multi-modal and longitudinal patient data.
• Ability to integrate a customer's own proprietary data to further enrich analysis.
• Access to a global data partner network of 150+ partners, including hospitals, research sites, and key opinion leaders worldwide.

Key Capabilities

• AI-guided tools for querying and analyzing complex patient-level data with confidence.
• Secure, GDPR+ compliant Trusted Research Environments that uphold the highest privacy and security standards.
• Federated architecture enabling secure collaboration and data access without centralizing sensitive information.
• Support for the full drug development lifecycle, from discovery and development through regulatory approval and market access.
• Harmonization, anonymization, and commercialization of healthcare data through revenue-sharing programs for data partners.
• Population health decision support for national healthcare initiatives and standards of care improvement.

Industries Served and Use Cases

• Life sciences: Advancing discovery and development, securing regulatory approval, and maximizing market access using multi-modal data — including structured imaging data — sourced and harmonized across multiple settings in a single, secure environment.
• Healthcare: Enabling healthcare organizations to anonymize, monetize, and safely store treatment data, participate in revenue-based projects, accelerate research and innovation, advance precision medicine, and conduct secure, compliant research.
• Supporting the creation of personalized therapies that improve patient outcomes and reduce costs for payers.
• Providing novel data insights that enhance care quality, reduce costs for payers and providers, and minimize waste.

Deployment, Compliance, and Integrations

• Compliant with EHDS and GDPR+ standards across all solutions.
• BC Mosaic TRE is available on AWS Marketplace, enabling cloud-based secure federated data analysis.
• Integration with NVIDIA accelerated computing within the BC Mosaic TRE for high-performance analytics.
• Technology deployed across 150+ global sites, serving customers and partners in the US, Europe, Asia-Pacific, and the Middle East.
• Regulatory-compliant audit trails built into research environments to support submissions and governance requirements.

BC Platforms continues to grow its global data partner ecosystem, inviting healthcare organizations to join a pioneering network that accelerates medical breakthroughs, enhances clinical decision-making, and drives personalized care — all while creating shared commercial value through collaborative revenue programs.